| 英文名稱 | Anti-CD30 (brentuximab vedotin biosimilar) mAb |
|---|---|
| 中文名稱 | 本妥昔單抗 |
| CAS號(hào) | 914088-09-8 |
| 儲(chǔ)存條件 | Sealed and stored at ≤-20℃, away from light. Avoid freeze-thaw cycles |
| 規(guī)格 | 庫(kù)存 | 目錄價(jià) | 會(huì)員專享價(jià) | 數(shù)量 |
|---|---|---|---|---|
| 1 mg | 3-5days | ¥7500.00 | 登錄后可見(jiàn) | |
| 5 mg | 3-5days | ¥35600.00 | 登錄后可見(jiàn) | |
| 10 mg | 3-5days | ¥64000.00 | 登錄后可見(jiàn) |
| 英文名稱 | Anti-CD30 (brentuximab vedotin biosimilar) mAb |
|---|---|
| 中文名稱 | 本妥昔單抗 |
| CAS號(hào) | 914088-09-8 |
| 儲(chǔ)存條件 | Sealed and stored at ≤-20℃, away from light. Avoid freeze-thaw cycles |
Brentuximab vedotin (SGN-35; Adcetris,cAC10-vcMMAE) is an anti-CD30 antibody conjugated via a protease-cleavable linker to the potent anti-microtubule agent monomethyl auristatin E (MMAE). Brentuximab vedotin can be used for the research of relapsed and refractory Hodgkin lymphoma.